Although few conclusive research studies have attempted to identify specific biomarkers, Ehtewish et al. showed that C-reactive protein, tau protein, brain-derived neurotrophic factor, advanced glycation end products, glycosylated hemoglobin, and adipokines should be considered in diabetes-related cognitive decrements [194]. This evidence concerns the gene MAPT and diabetes mellitus.